Race Against a Rare Ebola: Clinical Trial and Vaccine Drive Launch for Fast-Moving Outbreak

Loading...

Please wait while we get things ready for you

Lavamgam

The whole news day, read for you in 5 minutes.

Instagram

Product

News
Summaries
Analysis
AI Chat
Newsletter
RSS Feed

Company

About Us
Features
Pricing
Contact Us
Help Center

Legal

Privacy Policy
Terms of Service
Cookie Policy
Refund Policy
Report Content

Race Against a Rare Ebola: Clinical Trial and Vaccine Drive Launch for Fast-Moving Outbreak | Lavamgam

Health

Negative

Race Against a Rare Ebola: Clinical Trial and Vaccine Drive Launch for Fast-Moving Outbreak

The Bundibugyo ebolavirus outbreak tearing through Central Africa is about to meet its first real test: a clinical trial launching next week in the Democratic Republic of Congo will test Gilead Sciences' remdesivir and MappBio's monoclonal antibody MBP-134 against a strain that has no approved treatments or vaccines.